The contract from the Small Business Research Initiative (“SBRI”), administered by Innovate UK, will be used to make the Company’s epidermicin NI01 antibiotic ready for phase 1 human
The post Amprologix wins DHSC backing for new antibiotic appeared first on Pharmaceutical Business review.
Original Article: Amprologix wins DHSC backing for new antibiotic